Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2009 February;57(1) > Minerva Cardioangiologica 2009 February;57(1):77-94

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  VASCULAR INTERVENTIONS 2009


Minerva Cardioangiologica 2009 February;57(1):77-94

language: English

Coronary artery restenosis: a paradigm of current treatment approaches

Kiernan T. J., Kiernan G. D., Yan B. P.

1 Section of Vascular Medicine and Cardiology Intervention Division of Cardiology Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
2 University College Dublin Medical School Dublin, Ireland
3 Division of Cardiology Department of Medicine and Therapeutics Prince of Wales Hospital, Chinese University of Hong Kong, Hong Hong, China
4 Department of Epidemiology and Preventive Medicine Centre of Cardiovascular Research, Education and Therapeutics Monash University, Melbourne, Australia


PDF  


Percutaneous coronary artery revascularization has now evolved to a status where angioplasty and stenting have become routine practice for the treatment of significant obstructive atherosclerotic vascular disease. Angioplasty and stenting have become routine practice for the treatment of significant obstructive atherosclerotic vascular disease. Neointimal formation is the pathological basis for restenosis after coronary angioplasty and stenting. The authors discuss the current methods to treat and prevent coronary artery restenosis.

top of page

Publication History

Cite this article as

Corresponding author e-mail